B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19 pandemic due to their impaired response to infection and vaccination. Specifically, patients with common variable immunodeficiency (CVID) generated poor spike-specific antibody and T cell responses after immu...

Полное описание

Библиографические подробности

Главные авторы:	Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, Sara Terreri, Eva Piano Mortari, Concetta Quintarelli, Stefano Di Cecca, Gianluca Lagnese, Alessandra Punziano, Marika Guercio, Livia Bonanni, Stefania Auria, Francesca Villani, Christian Albano, Franco Locatelli, Giuseppe Spadaro, Rita Carsetti, Isabella Quinti
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2021-10-01
Серии:	Cells
Предметы:	common variable immunodeficiencies SARS-CoV-2 COVID-1 BNT162b2 vaccine third dose
Online-ссылка:	https://www.mdpi.com/2073-4409/10/11/2915
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!